Stock BLUE BLUEBIRD BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News bluebird bio, Inc.

Equities

BLUE

US09609G1004

Real-time Estimate Cboe BZX
Other stock markets
 09:51:58 2024-05-20 am EDT 		5-day change 1st Jan Change
1.055 USD +2.43% Intraday chart for bluebird bio, Inc. +0.99% -25.36%
May. 16 Transcript : Bluebird bio, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09 Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BLUE Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
BU
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
PR
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
PR
Transcript : Bluebird bio, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline
PR
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
PR
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm
PR
BLUE Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
BU
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
PR
Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
PR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
PR
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
NE
Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024
Bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
BU
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
PR
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE
PR
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
PR
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
PR
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUE
PR
Bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLUE Stock
  4. News bluebird bio, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW